Skip to main content
  • nl
  • fr
  • de
  • en
Other official information and services: www.belgium.be
Logo of the Belgian Federal Authorities
Return to the Volksgezondheid homepage federal public service
HEALTH, FOOD CHAIN SAFETY AND ENVIRONMENT
  • Profession
  • Documents
  • Advisory and consultative bodies
  • Theme
Home / Guidance for sponsors on the use of electronic informed consent in interventional clinical trials in Belgium

Guidance for sponsors on the use of electronic informed consent in interventional clinical trials in Belgium

Information

This document describes the restrictions that should be taken into account when using electronic methods to inform a potential participant of a clinical trial and/or to have the ICF signed.

application/pdf e-ICF guidance Belgium v2.0

Extra Information

Overlegorgaan: 
CT-College (Clinical Trial College)
Last modified: 
29-06-2022
Publication date: 
30-09-2020

Last documents published

advice_for_ecs_safety_assessment_final_20220603.pdf

application/pdf advice_for_ecs_safety_assessment_final_20220603.pdf

Advice for Belgian ECs regarding the assessment of safety reports in CTR applications

03-06-2022
Publications›Advices
CT-College (Clinical Trial College)
ethics committee

20210526_hospital_phase_1b.pdf

application/pdf 20210526_hospital_phase_1b.pdf

20210526_hospital_phase_1b.pdf

28-05-2021

20210526_hospital_phase_1a.pdf

application/pdf 20210526_hospital_phase_1a.pdf

20210526_Hospital_Phase_1A

28-05-2021

20210512_second_wave_phase_1b.pdf

application/pdf 20210512_Second_wave_Phase_1B

20210512_Second_wave_Phase_1B

12-05-2021

htsc_-new_surge_capacity_3rd_wave_-_phase_1a.pdf

application/pdf 11/03/2021 – HTSC – New surge capacity 3rd wave – phase 1A

11/03/2021 – HTSC – New surge capacity 3rd wave – phase 1A

02-04-2021
View all documents

© 2015 - FPS Health, Food chain safety and Environment

  • Legal information
  • Privacy

Contact

avenue Galilée | Galileelaan, 5 box 2
1210 Brussels

+32 (0)2 524.97.97

Fill in an online form

  • facebook
  • twitter
  • linkedin
  • Google+